drugset / Trial / NCT05950906
Study to Assess PDM608 in Healthy Adult Subjects
Phase 1
Completed
64 enrolled
Calibr, a division of Scripps Research
Alzheimer's Drug Discovery Foundation · collabMichael J. Fox Foundation for Parkinson's Research · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of PDM608 in healthy adult subjects.
Timeline
- Start
- 2023-06-27
- Primary completion
- 2024-03-17
- Completion
- 2024-04-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PDM608 | Unknown | — | Subcutaneous |